Search

Your search keyword '"Middeldorp, S."' showing total 268 results

Search Constraints

Start Over You searched for: Author "Middeldorp, S." Remove constraint Author: "Middeldorp, S." Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
268 results on '"Middeldorp, S."'

Search Results

1. Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.

2. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

3. Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial

4. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19.

5. Concerns about the ALIFE2 trial - Authors' reply

6. [Venous thromboembolism and antiphospholipid syndrome - considerations on diagnosis and treatment].

7. The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score's functional disability component.

9. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.

10. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis.

11. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data.

12. Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study.

13. Thromboprophylaxis in critical care.

14. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes Meta-Analysis of Randomized Trials

15. Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period: a Danish nationwide cohort study.

16. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.

18. Thromboprophylaxis in critical care.

19. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes Meta-Analysis of Randomized Trials

20. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis.

21. [Venous thromboembolism and antiphospholipid syndrome - considerations on diagnosis and treatment].

22. Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study.

23. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data.

24. The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score's functional disability component.

25. Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

26. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.

27. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.

28. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.

31. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial.

32. Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation.

33. Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV study.

34. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19.

35. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing.

36. Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study

37. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination

38. Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial

39. Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracereoral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care

40. Pregnancy outcomes in women with Budd-Chiari syndrome or portal vein thrombosis - a multicentre retrospective cohort study

41. Growth differentiation factor-15 for prediction of bleeding in cancer patients

42. Splanchnic vein thrombosis-related mortality in the Veneto region (Italy), 2008-2019: Retrospective analysis of epidemiological data

43. Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?

44. Interne geneeskunde, fundament voor de toekomst

45. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination

46. Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment

47. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

48. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

49. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

50. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin

Catalog

Books, media, physical & digital resources